# US 2021/0275705 A1 · Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275705 A1
- Document ID: US20210275705A1
- Status: Published application
- Kind: A1
- Application number: 16/984,366
- Filed: 2020-08-04
- Published: 2021-09-09
- Earliest claimed: 2020-03-03
- Assignees: Helios Shield Ltd.
- Applicants: Helios Shield Ltd
- Inventors: Andrew Clark Baird Aubert
- Web page: https://patentgrep.com/patent/US20210275705A1

## CPC

- A61L 2/24: Apparatus using programmed or automatic operation
- A61L 2/10: Ultraviolet [UV] radiation
- A61L 2103/05: Living organisms or biological materials
- A61L 2103/75: Room floors or walls
- A61L 2202/11: Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
- A61L 2202/14: Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A UVA/UVC system for reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said system includes: iv) at least one UVA light source; v) at least one UVC light source; and at least one controller connected to each of the at least one UVA light source and the at least one UVC light source, for controlling at least one parameter of each of the UVA light source and UVC light source.

## Claims

### Claim 1

A UVA/UVC system for reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said system comprises:
i) at least one UVA light source;
ii) at least one UVC light source; and
iii) at least one controller connected to each of said at least one UVA light source and said at least one UVC light source, for controlling at least one parameter of each of said UVA light source and UVC light source selected from light source, light intensity, radiated power level, wavelength, exposure time and combinations thereof; wherein said at least one UVC light source emits UVC light to a surface for a period of time reducing the level of said harmful entity on said surface to a level that is safe to humans, and said at least one UVA light source emits UVA light to a surface for a period of time inhibiting growth of said harmful entity on said surface, such that during the time said at least one UVC light source and said at least one UVA light source is emitting on said surface, radiation levels from said at least one UVC light source and said at least one UVA light source is safe to humans; wherein when said at least one UVC light source is emitting UVA light to said surface, said at least one UVC light is off, and when said at least one UVA light source is emitting light to aid surface, said at least one UVC light source is off; wherein cycling between said at least one UVC light source and said at least one UVA light source is controlled by said at least one controller.

### Claim 2 (depends on 1)

The system of claim 1, wherein said at least one UVC light source has an operating wavelength of from about 275 nanometers (nm) to about 295 nm. In one alternative, said at least one UVC light source has an operating wavelength of about 275 nm.

### Claim 3 (depends on 1)

The system of claim 1 wherein said at least one UVA light source has an operating wavelength of from about 385 nm to about 405 nm. In one alternative, said at least one UVA light source has an operating wavelength of about 405 nm.

### Claim 4 (depends on 1)

The system of claim 1 wherein said at least one UVC light source is a light emitting diode (LED).

### Claim 5 (depends on 1)

The system of claim 1 wherein said at least one UVA light source is a LED.

### Claim 6 (depends on 1)

The system of claim 1 wherein the at least one controller automatically cycles between emitting light from said at least one UVA light source and from said at least one UVC light source.

### Claim 7 (depends on 1)

The system of claim 1 wherein said at least one UVC light source has an emission at a power level and time duration to reduce at least one pathogen on a surface exposed to said at least one UVC light source.

### Claim 8 (depends on 1)

The system of claim 1 wherein the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.

### Claim 9 (depends on 1)

The system of claim 1 wherein the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.

### Claim 10 (depends on 1)

The system of claim 1 wherein said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.

### Claim 11 (depends on 1)

The system of claim 1 wherein said at least one UVC light source has a power rating of from about 10 mW to about 100 W.

### Claim 12 (depends on 11)

The system of claim 11, wherein said at least one UVC light source has a power rating of 244 mW.

### Claim 13 (depends on 1)

The system of claim 1 wherein said at least one UVA light source has a power rating of from about 10 mW to about 100 W.

### Claim 14 (depends on 13)

The system of claim 13, wherein said at least one UVA light source has a power rating of 20 mW.

### Claim 15 (depends on 1)

The system of claim 1 wherein said system reduces the level of at least one pathogen on a surface exposed to said system by 1 to 100%. In one alternative, by 10 to 20%.

### Claim 16 (depends on 1)

The system of claim 1 wherein said system reduces the level of at least one pathogen on a surface exposed to said system by 10 to 20%.

### Claim 17

A method of reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said method has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said method comprises:
i) exposing said surface to at least one UVC light source for a period of time to reduce the level of least one pathogen on said surface;
ii) terminating the exposure of the at least one UVC light source on said surface;
iii) exposing said UVC exposed surface to at least one UVA light source for a period of time to inhibit growth of least one pathogen on said surface;
iv) terminating the exposure of the at least one UVA light source on said surface;
v) optionally repeating steps i) to iv) in order to maintain a desired level of least one pathogen on said surface.

### Claim 18 (depends on 16)

The method of claim 16, wherein said at least one UVC light source has an operating wavelength of from about 275 nanometers (nm) to about 295 nm.

### Claim 19 (depends on 16)

The method of claim 16, wherein said at least one UVC light source has an operating wavelength of about 275 nm.

### Claim 20 (depends on 16)

The method of claim 16, wherein said at least one UVA light source has an operating wavelength of from about 385 nm to about 405 nm.

### Claim 21 (depends on 16)

The method of claim 16, wherein said at least one UVA light source has an operating wavelength of about 405 nm.

### Claim 22 (depends on 16)

The method of claim 16, wherein said at least one UVC light source is a light emitting diode (LED).

### Claim 23 (depends on 16)

The method of claim 16, wherein said at least one UVA light source is a LED.

### Claim 24 (depends on 16)

The method of claim 16, wherein steps i) to iv) are controlled by at least one controller automatically cycling between emitting light from said at least one UVA light source and from said at least one UVC light source.

### Claim 25 (depends on 16)

The method of claim 16, wherein said at least one UVC light source has an emission at a power level and time duration to reduce at least one pathogen on a surface exposed to said at least one UVC light source.

### Claim 26 (depends on 16)

The method of claim 16, wherein the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.

### Claim 27 (depends on 16)

The method of claim 16, wherein the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.

### Claim 28 (depends on 16)

The method of claim 16, wherein said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.

### Claim 29 (depends on 16)

The method of claim 16, wherein said at least one UVC light source has a power rating of from about 10 mW to about 100 W.

### Claim 30 (depends on 29)

The method of claim 29, wherein said at least one UVC light source has a power rating of 244 mW.

### Claim 31 (depends on 16)

The method of claim 16, wherein said at least one UVA light source has a power rating of from about 10 mW to about 100 W.

### Claim 32 (depends on 31)

The method of claim 31, wherein said at least one UVA light source has a power rating of 20 mW.

### Claim 33 (depends on 16)

The method of claim 16, wherein said method reduces the level of at least one pathogen on a surface by 1 to 100%.

### Claim 34 (depends on 33)

The method of claim 33 wherein said level is reduced by 10 to 20%.

### Claim 35 (depends on 1)

The system of claim 1, for the reduction of at least one pathogen selected from the group consisting of E. Coli K12, S. Epidermis and B. Subtilis.

### Claim 36 (depends on 16)

The method of claim 16, for the reduction of at least one pathogen selected from the group consisting of E. Coli K12, S. Epidermis and B. Subtilis.
